Jesús Martin-Garcia
Chief Executive Officer at GENEURO SA
Network origin in Jesús Martin-Garcia first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
20
| Public Company | Biotechnology | 20 |
| Subsidiary | Pharmaceuticals: Major | 8 | |
Harvard Business School Health Industry Alumni Association
6
| Non-Profit Organization | 6 | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.
4
| Subsidiary | Pharmaceuticals: Generic | 4 |
GeNeuro SA
 GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The company is based in Lyon, France.
3
| Subsidiary | Biotechnology | 3 |
Eclosion2 SA
 Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services.
2
| Private Company | Financial Conglomerates | 2 |
Union des Associations Patronales Genevoises
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jesús Martin-Garcia via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Graduate Degree Masters Business Admin Masters Business Admin | |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| TRANSGENE | Biotechnology | Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
| University of Geneva | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| INSEAD | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
| Sciences Po | College/University | Undergraduate Degree Undergraduate Degree | |
TSGH SAS
 TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Financial Conglomerates | Chief Executive Officer Chairman | |
| Transgene, Inc. | Director/Board Member Director/Board Member | ||
| Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Director/Board Member Director/Board Member | ||
Fabentech SAS
 Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Medical/Nursing Services | Chairman Chairman | |
GeNeuro Innovation SAS
 GeNeuro Innovation SAS Miscellaneous Commercial ServicesCommercial Services Part of GeNeuro SA (Switzerland), GeNeuro Innovation SAS is a French company that specializes in developing therapeutic products for the treatment of neurological disorders such as multiple sclerosis, schizophrenia, and autoimmune disorders like diabetes. The company focuses on developing new therapeutics that address nervous system pathologies involving human endogenous retroviruses (HERVs). | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Graduate Degree | |
Advanced BioScience Laboratories, Inc.
 Advanced BioScience Laboratories, Inc. Medical/Nursing ServicesHealth Services Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member Chairman | |
| INNATE PHARMA | Pharmaceuticals: Major | Corporate Officer/Principal Founder | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Creabilis SA | Director/Board Member Director/Board Member | ||
| University of Lausanne | College/University | Graduate Degree Doctorate Degree | |
Servier IP UK Ltd.
 Servier IP UK Ltd. Medical DistributorsDistribution Services Part of Baxter International, Inc., Servier IP UK Ltd. is a company that wholesales pharmaceutical products. Servier IP UK Ltd. is based in Slough, UK. Servier IP was acquired by Baxter International, Inc. from Essetifin SpA on July 23, 2015 for $1,255.92 million. | Medical Distributors | Director/Board Member Chief Executive Officer | |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Director/Board Member | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin | |
| High Council For Evaluation of Research & Higher Education | Director/Board Member | ||
| SPEXIS AG | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Strasbourg | College/University | Doctorate Degree | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member | |
| IPSEN | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Queen's School of Medicine | College/University | Graduate Degree | |
Farmindustria
 Farmindustria Miscellaneous Commercial ServicesCommercial Services Farmindustria is an association of pharmaceutical companies that are based in Italy. The private company provides an interactive map that shows the location of their offices, production sites, and research centers. Farmindustria is located in Rome, Italy. The Italian company promotes the value of the pharmaceutical industry in terms of employment, investment, innovation, research and development, production, and export. The company also provides updates on COVID-19 and information on the pharmaceutical industry. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer Holding France SCA
 Pfizer Holding France SCA Pharmaceuticals: MajorHealth Technology Pfizer Holding France SCA manufactures and supplies pharmaceutical products. The company was founded in 1961 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
NTC SRL
 NTC SRL Pharmaceuticals: GenericHealth Technology NTC SRL manufactures generic drugs, nutraceutical and pharmaceutical products. It develops and produces generic drugs for specialist therapies, innovative medical devices and high quality food supplements. The company was founded by Nicola Travierso in 1997 and is headquartered in Milan, Italy. | Pharmaceuticals: Generic | Director/Board Member | |
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
DNA Script SAS
 DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Peptomyc SL
 Peptomyc SL Pharmaceuticals: MajorHealth Technology Peptomyc SL develops cell penetrating peptides targeting the Myc oncoprotein for cancer treatment. The company was founded by Marie-Eve Beaulieu and Laura Soucek on December 16, 2014 and is headquartered in Barcelona, Spain. | Pharmaceuticals: Major | Chairman | |
Bertrand Vigouroux SA
 Bertrand Vigouroux SA Home Improvement ChainsRetail Trade Bertrand Vigouroux SA retails and wholesales garden products. The company is headquartered in Grasse, France. | Home Improvement Chains | Chairman | |
Farmabios SpA
 Farmabios SpA Pharmaceuticals: MajorHealth Technology Farmabios SpA engages in the manufacture and marketing of active ingredients for pharmaceutical applications. It offers oral cephalosporins, steroids hormones, highly potent substances, multipurpose plant for steroids, sterile cephalosporins, sterile steroids, and antineoplastics. The company was founded in 1961 and is headquartered in Gropello Cairoli, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman | |
| ABIVAX | Pharmaceuticals: Other | Director/Board Member | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Executive Officer | |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistics
International
| France | 20 |
| Switzerland | 10 |
| United States | 8 |
| Italy | 6 |
| United Kingdom | 4 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 10 |
| Commercial Services | 4 |
| Health Services | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 225 |
| Corporate Officer/Principal | 96 |
| Independent Dir/Board Member | 55 |
| Chairman | 50 |
| Chief Executive Officer | 28 |
Most connected contacts
| Insiders | |
|---|---|
| Benoît Habert | 34 |
| Elmar Schnee | 31 |
| Catherine Moukheibir | 29 |
| Renée Aguiar-Lucander | 26 |
| Claudio Nessi | 25 |
| Philippe Archinard | 24 |
| Todd Davis | 23 |
| Cecilia Gonzalo | 20 |
| Claude Bertrand | 20 |
| Gilles Nobécourt | 19 |
| Mary C. Tanner | 17 |
| Claude Bagnoud | 17 |
| Giacomo di Nepi | 16 |
| Hedi Brahim | 13 |
| Elias Papatheodorou | 13 |
- Stock Market
- Insiders
- Jesús Martin-Garcia
- Company connections
